Largest health care companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
UnitedHealth Group leads the 170 health care companies ranked by net assets, at NOK 968.2B, ahead of Pfizer (NOK 836.5B) and Johnson & Johnson (NOK 788.8B). Figures as of 19 Nov 2026, 10:28 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupNOK 968.2B
- Median
- NOK 24.9B
- Combined market value
- NOK 87.98T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Kymera TherapeuticsKYMR · Health Care | NOK 15.3B | NOK 100B | NOK 1,171.71 | 0.32% down | 87% up | ||
| 102 | LifeStance Health GroupLFST · Health Care | NOK 14.7B | NOK 50.6B | NOK 133.20 | 2.82% down | 129% up | ||
| 103 | InsuletPODD · Health Care | NOK 14.7B | NOK 93.9B | NOK 1,354.05 | 3.69% down | 58% down | ||
| 104 | CencoraCOR · Health Care | NOK 14.6B | NOK 642.9B | NOK 3,369.25 | 0.64% down | 3% down | ||
| 105 | PenumbraPEN · Health Care | NOK 13.8B | NOK 122.2B | NOK 3,101.21 | 0.47% up | 13% up | ||
| 106 | MSA SafetyMSA · Health Care | NOK 13.2B | NOK 66.1B | NOK 1,716.50 | 2.67% up | 11% up | ||
| 107 | Option Care HealthOPCH · Health Care | NOK 12.8B | NOK 45.9B | NOK 306.74 | 0.25% up | 14% up | ||
| 108 | Krystal BiotechKRYS · Health Care | NOK 11.8B | NOK 90.4B | NOK 3,050.33 | 5.62% up | 46% up | ||
| 109 | LivaNovaLIVN · Health Care | NOK 11.6B | NOK 50.4B | NOK 914.50 | 2.85% up | 71% up | ||
| 110 | RadNetRDNT · Health Care | NOK 10.5B | NOK 54.7B | NOK 694.73 | 4.14% down | 7% down | ||
| 111 | Lantheus HoldingsLNTH · Health Care | NOK 10.5B | NOK 64.5B | NOK 986.66 | 0.20% up | 93% up | ||
| 112 | Ligand PharmaceuticalsLGND · Health Care | NOK 9.8B | NOK 57.8B | NOK 2,889.47 | 1.67% up | 43% up | ||
| 113 | Legend BiotechLEGN · Health Care | NOK 9.7B | NOK 30.5B | NOK 157.19 | 0.87% up | 42% down | ||
| 114 | ChemedCHE · Health Care | NOK 9.5B | NOK 68.5B | NOK 5,288.50 | 0.01% down | 27% up | ||
| 115 | Oscar HealthOSCR · Health Care | NOK 9.5B | NOK 82.9B | NOK 266.69 | 7.61% down | 112% up | ||
| 116 | PACS GroupPACS · Health Care | NOK 9.2B | NOK 71.1B | NOK 447.87 | 4.63% down | 188% up | ||
| 117 | Praxis Precision MedicinesPRAX · Health Care | NOK 8.5B | NOK 82.5B | NOK 2,952.15 | 0.04% up | 61% up | ||
| 118 | ImmunovantIMVT · Health Care | NOK 8.2B | NOK 66.4B | NOK 320.86 | 0.12% down | 43% up | ||
| 119 | 10x GenomicsTXG · Health Care | NOK 7.7B | NOK 72.6B | NOK 552.05 | 1.37% up | 260% up | ||
| 120 | HaemoneticsHAE · Health Care | NOK 7.7B | NOK 54.1B | NOK 1,188.44 | 1.60% up | 61% up | ||
| 121 | Alnylam PharmaceuticalsALNY · Health Care | NOK 7.6B | NOK 193.6B | NOK 1,445.17 | 4.54% down | 66% down | ||
| 122 | Belite BioBLTE · Health Care | NOK 7.5B | NOK 61.4B | NOK 1,511.24 | 0.94% down | 31% up | ||
| 123 | CG OncologyCGON · Health Care | NOK 7.3B | NOK 69.1B | NOK 773.85 | 1.34% up | 85% up | ||
| 124 | InsmedINSM · Health Care | NOK 7.1B | NOK 254.2B | NOK 1,158.84 | 1.69% down | 40% down | ||
| 125 | Spyre TherapeuticsSYRE · Health Care | NOK 6.9B | NOK 93.2B | NOK 981.44 | 8.15% up | 286% up | ||
| 126 | Summit TherapeuticsSMMT · Health Care | NOK 6.4B | NOK 81.2B | NOK 101.57 | 1.59% down | 36% down | ||
| 127 | GlaukosGKOS · Health Care | NOK 6.3B | NOK 133.5B | NOK 2,254.62 | 4.18% down | 152% up | ||
| 128 | TG TherapeuticsTGTX · Health Care | NOK 6.3B | NOK 96.7B | NOK 639.59 | 5.44% up | 107% up | ||
| 129 | Corcept TherapeuticsCORT · Health Care | NOK 6.3B | NOK 71.8B | NOK 655.74 | 3.25% down | 8% down | ||
| 130 | Cogent BiosciencesCOGT · Health Care | NOK 6.2B | NOK 46.8B | NOK 269.01 | 0.14% down | 20% down | ||
| 131 | Protagonist TherapeuticsPTGX · Health Care | NOK 5.9B | NOK 80.3B | NOK 1,230.04 | 2.00% up | 46% up | ||
| 132 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 5.8B | NOK 89.4B | NOK 3,850.69 | 5.67% down | 24% down | ||
| 133 | Caris Life SciencesCAI · Health Care | NOK 5.6B | NOK 54.1B | NOK 188.63 | 2.21% down | 17% down | ||
| 134 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 5.5B | NOK 72.2B | NOK 919.43 | 0.06% down | 126% up | ||
| 135 | Hims & Hers HealthHIMS · Health Care | NOK 5.2B | NOK 38.7B | NOK 164.93 | 2.85% down | 51% down | ||
| 136 | Edgewise TherapeuticsEWTX · Health Care | NOK 5.1B | NOK 43.8B | NOK 400.18 | 1.59% down | 88% up | ||
| 137 | ABIVAXABVX · Health Care | NOK 4.9B | NOK 71B | NOK 810.90 | 2.11% up | 27% down | ||
| 138 | Dianthus TherapeuticsDNTH · Health Care | NOK 4.8B | NOK 45.7B | NOK 812.35 | 3.45% down | 113% up | ||
| 139 | Ionis PharmaceuticalsIONS · Health Care | NOK 4.7B | NOK 44.1B | NOK 264.95 | 1.59% up | 64% down | ||
| 140 | BillionToOneBLLN · Health Care | NOK 4.6B | NOK 42.3B | NOK 885.48 | 6.11% down | 0% up | ||
| 141 | Twist BioscienceTWST · Health Care | NOK 4.6B | NOK 76.7B | NOK 1,125.47 | 3.88% up | 340% up | ||
| 142 | Oruka TherapeuticsORKA · Health Care | NOK 4.6B | NOK 62.8B | NOK 926.11 | 0.60% down | 241% up | ||
| 143 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 4.5B | NOK 59B | NOK 417.01 | 0.28% up | 10% up | ||
| 144 | Medpace HoldingsMEDP · Health Care | NOK 4.4B | NOK 175B | NOK 6,257.27 | 0.95% down | 10% up | ||
| 145 | Concentra Group Holdings ParentCON · Health Care | NOK 3.8B | NOK 51.1B | NOK 406.08 | 0.94% down | 120% up | ||
| 146 | Definium TherapeuticsDFTX · Health Care | NOK 3.2B | NOK 38.6B | NOK 281.68 | 0.88% down | 169% up | ||
| 147 | ErascaERAS · Health Care | NOK 3.1B | NOK 46.7B | NOK 133.10 | 0.94% down | 403% up | ||
| 148 | Mirum PharmaceuticalsMIRM · Health Care | NOK 3B | NOK 58.4B | NOK 894.67 | 0.59% up | 31% up | ||
| 149 | HeartflowHTFL · Health Care | NOK 2.9B | NOK 39B | NOK 443.90 | 2.51% down | 73% up | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | NOK 2.4B | NOK 56.6B | NOK 464.31 | 6.48% up | 14% up | ||
| 151 | Adaptive BiotechnologiesADPT · Health Care | NOK 2.1B | NOK 44.6B | NOK 275.30 | 0.11% down | 88% up | ||
| 152 | Kodiak SciencesKOD · Health Care | NOK 1.5B | NOK 61.9B | NOK 946.13 | 1.04% up | 396% up | ||
| 153 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 1.3B | NOK 79.8B | NOK 1,151.49 | 2.08% up | 13% up | ||
| 154 | Travere TherapeuticsTVTX · Health Care | NOK 1.1B | NOK 46.7B | NOK 485.98 | 1.68% down | 44% up | ||
| 155 | Axsome TherapeuticsAXSM · Health Care | NOK 854.1M | NOK 68.2B | NOK 1,296.20 | 1.43% down | 7% down | ||
| 156 | Halozyme TherapeuticsHALO · Health Care | NOK 472.2M | NOK 105.7B | NOK 926.69 | 0.18% down | 37% up | ||
| 157 | Mettler-Toledo InternationalMTD · Health Care | -NOK 228.6M | NOK 334.3B | NOK 16,804.78 | 1.42% up | 22% up | ||
| 158 | Amneal PharmaceuticalsAMRX · Health Care | -NOK 684.8M | NOK 73.7B | NOK 211.65 | 3.60% up | 83% up | ||
| 159 | Guardant HealthGH · Health Care | -NOK 960.6M | NOK 189.9B | NOK 1,403.96 | 1.30% up | 44% up | ||
| 160 | VeradermicsMANE · Health Care | -NOK 1.2B | NOK 51B | NOK 1,207.79 | 0.62% down | 233% up | ||
| 161 | Ascendis PharmaASND · Health Care | -NOK 1.7B | NOK 171.5B | NOK 2,614.94 | 0.32% down | 28% up | ||
| 162 | PTC TherapeuticsPTCT · Health Care | -NOK 2B | NOK 48.7B | NOK 582.61 | 0.22% down | 20% down | ||
| 163 | ImmunityBioIBRX · Health Care | -NOK 4.8B | NOK 68.9B | NOK 64.81 | 7.03% up | 193% up | ||
| 164 | DaVitaDVA · Health Care | -NOK 6.3B | NOK 98.4B | NOK 1,565.02 | 6.48% down | 50% up | ||
| 165 | CytokineticsCYTK · Health Care | -NOK 6.4B | NOK 69.2B | NOK 496.43 | 0.64% down | 20% down | ||
| 166 | BridgeBio PharmaBBIO · Health Care | -NOK 20.2B | NOK 147B | NOK 754.60 | 1.58% up | 17% up | ||
| 167 | McKessonMCK · Health Care | -NOK 21B | NOK 1.21T | NOK 10,489.85 | 0.66% down | 28% up | ||
| 168 | Cardinal HealthCAH · Health Care | -NOK 27.9B | NOK 622.3B | NOK 2,692.23 | 0.33% down | 35% up | ||
| 169 | AbbVieABBV · Health Care | -NOK 31.6B | NOK 4.89T | NOK 2,766.62 | 2.33% down | 26% up | ||
| 170 | HCA HealthcareHCA · Health Care | -NOK 58.3B | NOK 962.5B | NOK 4,607.81 | 4.96% down | 4% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6731 NOK).
Questions and answers
Which health care companies rank first by net assets?
UnitedHealth Group (NOK 968.2B), Pfizer (NOK 836.5B) and Johnson & Johnson (NOK 788.8B) are the top three of the 170 health care companies ranked by net assets as of 19 Nov 2026, 10:28 UTC.
How many health care companies are in this ranking?
170 are ranked by net assets.
What are these health care companies worth together?
The 170 health care companies ranked by net assets have a combined market value of NOK 87.98T as of 19 Nov 2026, 10:28 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by net assets”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.